Skip to main content
NCBI home page
Nature Portfolio logoLink to Nature Portfolio
. 2024 Oct 28;30(12):3778. doi: 10.1038/s41591-024-03372-1

Author Correction: Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes

Muthiah Vaduganathan 1, Gerasimos Filippatos 2, Brian L Claggett 1, Akshay S Desai 1, Pardeep S Jhund 3, Alasdair Henderson 3, Meike Brinker 4, Peter Kolkhof 4, Patrick Schloemer 4, James Lay-Flurrie 4, Prabhakar Viswanathan 4, Carolyn S P Lam 5, Michele Senni 6, Sanjiv J Shah 7, Adriaan A Voors 8, Faiez Zannad 9, Peter Rossing 10, Luis M Ruilope 11, Stefan D Anker 12, Bertram Pitt 13, Rajiv Agarwal 14, John J V McMurray 3, Scott D Solomon 1,✉
PMCID: PMC11645292  PMID: 39468366

Correction to: Nature Medicine 10.1038/s41591-024-03264-4, published online 1 September 2024.

In the version of the article initially published, the first three columns of the “New-onset atrial fibrillation” row of Fig. 1 originally read “286 (3.0)”, “1.3”, “345 (3.6)” and have now been amended to “286 (3.9)”, “1.4”, “345 (4.7)” in the HTML and PDF versions of the article.

Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES